The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells.

emricasan (IDN 6556) - Amerimmune

cisplatin - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/39110182

Athanasia Warnecke; Axel Schambach; Jennifer Harre; Juliane W Schott; Larissa Nassauer; Melanie Galla; Michael Morgan

Aug 7, 2024